Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis
J. Clin. Invest. Craig E. Daniels, et al. 114:1308
doi:10.1172/JCI19603 [Go to this article.]

Problems with a PDF?